AARTI DRUGS LTD. - 524348 - Clarification On Announcement Dated Sept 20, 2024 .On USFDA Inspection At API Manufacturing Facility Of The Company

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Mid-range Performer

475.0000 6.05 (1.29%)

NSE Jun 03, 2025 09:44 AM

25.20% Fall from 52W High

Volume: 74,326

Aarti Drugs Ltd.

25 Sep 2024

475.00

1.29%

Company Update

AARTI DRUGS LTD. - 524348 - Clarification On Announcement Dated Sept 20, 2024 .On USFDA Inspection …

BSE India

Clarification on announcement dated Sept 20, 2024 on USFDA inspection at API manufacturing facility of the Company

More from Aarti Drugs Ltd.

Recommended

Market opens higher, Transrail Lighting wins orders worth Rs 534 crore in India and abroad

Trendlyne Marketwatch | 03 Jun 2025, 09:21AM

IPOs This Week: Prostarm, Scoda Tubes Plus Six Listings, and A New Issue

| 02 Jun 2025, 04:29PM

Earnings Call Transcript - Q1FY21 for Aarti Drugs